Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities.


Journal

The Journal of allergy and clinical immunology
ISSN: 1097-6825
Titre abrégé: J Allergy Clin Immunol
Pays: United States
ID NLM: 1275002

Informations de publication

Date de publication:
04 2021
Historique:
received: 20 03 2020
revised: 17 07 2020
accepted: 06 08 2020
pubmed: 5 10 2020
medline: 21 9 2021
entrez: 4 10 2020
Statut: ppublish

Résumé

Molecular studies in atopic dermatitis (AD) are largely restricted to patients with moderate-to-severe disease. Our aim was to evaluate skin and blood abnormalities in mild, moderate, and severe AD. Skin and blood samples were obtained from 61 patients with AD (20 with mild or limited disease, 17 with moderate disease, and 24 with severe disease) and 20 healthy subjects. Immune and barrier markers were measured in lesional, nonlesional, and healthy skin by quantitative real-time PCR and immunohistochemistry, and in blood by using the OLINK proteomic assay. Cellular markers of epidermal hyperplasia and T-cell/dendritic cell infiltration were increased in AD tissues of all patients in all severity groups versus in those of controls, whereas downstream T Mild and limited AD show high levels of T

Sections du résumé

BACKGROUND
Molecular studies in atopic dermatitis (AD) are largely restricted to patients with moderate-to-severe disease.
OBJECTIVE
Our aim was to evaluate skin and blood abnormalities in mild, moderate, and severe AD.
METHODS
Skin and blood samples were obtained from 61 patients with AD (20 with mild or limited disease, 17 with moderate disease, and 24 with severe disease) and 20 healthy subjects. Immune and barrier markers were measured in lesional, nonlesional, and healthy skin by quantitative real-time PCR and immunohistochemistry, and in blood by using the OLINK proteomic assay.
RESULTS
Cellular markers of epidermal hyperplasia and T-cell/dendritic cell infiltration were increased in AD tissues of all patients in all severity groups versus in those of controls, whereas downstream T
CONCLUSION
Mild and limited AD show high levels of T

Identifiants

pubmed: 33011244
pii: S0091-6749(20)31334-8
doi: 10.1016/j.jaci.2020.08.041
pii:
doi:

Substances chimiques

Cytokines 0
Proteome 0
RNA, Messenger 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1369-1380

Informations de copyright

Copyright © 2020 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Auteurs

Helen He (H)

Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY.

Ester Del Duca (E)

Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY.

Aisleen Diaz (A)

Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY.

Hyun Je Kim (HJ)

Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY.

Jesús Gay-Mimbrera (J)

Department of Dermatology, Reina Sofía University Hospital, Córdoba, Spain.

Ning Zhang (N)

Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY.

Jianni Wu (J)

Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY.

Jessica Beaziz (J)

Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY.

Yeriel Estrada (Y)

Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY.

James G Krueger (JG)

Laboratory of Investigative Dermatology, The Rockefeller University, New York, NY.

Ana B Pavel (AB)

Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY; Department of Biomedical Engineering, The University of Mississippi, Oxford, Miss.

Juan Ruano (J)

Department of Dermatology, Reina Sofía University Hospital, Córdoba, Spain.

Emma Guttman-Yassky (E)

Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: emma.guttman@mountsinai.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH